TP53 and cancer: Several genes involved in DNA damage sensing pathways, including the p53 pathway, were upregulated in treated conditions compared to untreated while downregulated genes included genes involved in cell cycle progression (e.g. mitotic genes such as BUB1 and TTK), confirming the induction of a proliferation arrest in cancer cells by both treatments (Fig. S4C).